DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. The Lancet. 2023;401:2073–86.

Article  CAS  Google Scholar 

Abdel-Aziz AK. Advances in acute myeloid leukemia differentiation therapy: a critical review. Biochem Pharmacol. 2023;215:115709.

Article  CAS  PubMed  Google Scholar 

Jamil A, Qureshi Z, El-amir ZM, Kupakuwana-Suk G, Akram H, Ahmad M, Huselton E. Targeting menin for precision therapy in high-risk acute myeloid leukemia. Leuk Res Rep. 2025;23:100495.

CAS  PubMed  Google Scholar 

Wysota M, Konopleva M, Mitchell S. Novel therapeutic targets in acute myeloid leukemia (AML). Curr Oncol Rep. 2024;26:409–20.

Article  PubMed  PubMed Central  Google Scholar 

Thomas X. Small molecule menin inhibitors: novel therapeutic agents targeting acute myeloid leukemia with KMT2A rearrangement or NPM1 mutation. Oncol Ther. 2024;12:57–72.

Article  PubMed  PubMed Central  Google Scholar 

Dempke WCM, Desole M, Chiusolo P, Sica S, Schmidt-Hieber M. Targeting the undruggable: menin inhibitors ante portas. J Cancer Res Clin Oncol. 2023;149:9451–9.

Article  CAS  PubMed  Google Scholar 

Gundry MC, Goodell MA, Brunetti L. It’s all about MEis: menin-MLL inhibition eradicates NPM1-mutated and MLL-rearranged acute leukemias in mice. Cancer Cell. 2020;37:267–9.

Article  CAS  PubMed  Google Scholar 

Krivtsov AV, Evans K, Gadrey JY, et al. A menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia. Cancer Cell. 2019;36:660-673.e11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Candoni A, Coppola G. A 2024 update on menin inhibitors. A new class of target agents against KMT2A-rearranged and NPM1-mutated acute myeloid leukemia. Hematol Rep. 2024;16:244–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Issa GC, Aldoss I, DiPersio J, et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature. 2023;615:920–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fareed A, Inam N, Faraz F. Breakthrough treatment choice for acute myeloid leukemia in pediatric and adult patients: revumenib, an oral selective inhibitor of KMTA2Ar. Rare Tumors. 2023;15:203636132311837.

Article  Google Scholar 

Aldoss I, Issa GC, Thirman MJ, et al. Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemias: efficacy and safety results from the Augment-101 phase 1/2 study. Blood. 2023;142:2907–2907.

Article  Google Scholar 

Aldoss I, Issa GC, Thirman M, et al. Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemia: topline efficacy and safety results from the pivotal Augment-101 phase 2 study. Blood. 2023;142:LBA-5-LBA−5.

Article  Google Scholar 

Zucenka A, Issa GC, Arellano M, et al. Revumenib maintenance therapy following revumenib-induced remission and transplant. Blood. 2023;142:4950–4950.

Article  Google Scholar 

Issa GC, Ambinder AJ, Xiao W, et al. A multi-site break through cancer trial: phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress). Blood. 2024;144(4265.2–4265):2.

Google Scholar 

Issa GC, Cuglievan B, DiNardo CD, et al. Early results of the phase I/II study investigating the all-oral combination of the menin inhibitor revumenib (SNDX-5613) with decitabine/cedazuridine (ASTX727) and venetoclax in acute myeloid leukemia (SAVE). Blood. 2023;142:58–58.

Article  Google Scholar 

Hu M, Li W, Zhang Y, Liang C, Tan J, Wang Y. Venetoclax in adult acute myeloid leukemia. Biomed Pharmacother. 2023;168:115820.

Article  CAS  PubMed  Google Scholar 

Oyogoa E, Traer E, Tyner J, Lachowiez C. Building on foundations: venetoclax-based combinations in the treatment of acute myeloid leukemia. Cancers (Basel). 2023;15:3589.

Article  CAS  PubMed  Google Scholar 

Fang Z, Zhang H, Guo J, Guo J. Overview of therapeutic drug monitoring and clinical practice. Talanta. 2024;266:124996.

Article  CAS  PubMed  Google Scholar 

Ates HC, Roberts JA, Lipman J, Cass AEG, Urban GA, Dincer C. On-site therapeutic drug monitoring. Trends Biotechnol. 2020;38:1262–77.

Article  CAS  PubMed  Google Scholar 

Chen L, Zhang Y, Zhang Y-X, Wang W-L, Sun D-M, Li P-Y, Feng X-S, Tan Y. Pretreatment and analysis techniques development of TKIs in biological samples for pharmacokinetic studies and therapeutic drug monitoring. J Pharm Anal. 2024;14:100899.

Article  PubMed  Google Scholar 

Lucena R, Cárdenas S. Analytical sample treatment: basics and trends. In: Analytical sample preparation with nano- and other high-performance materials. Elsevier, 2021;pp 1–11

Flores J, Nevado J, Penalvo G, Diez N. Development and validation method for determination of fluoxetine and its main metabolite norfluoxetine by nonaqueous capillary electrophoresis in human urine. Talanta. 2005;65:163–71.

Article  CAS  PubMed  Google Scholar 

Nevado JJB, Peñalvo GC, Dorado RMR, Robledo VR. Simultaneous determination of omeprazole and their main metabolites in human urine samples by capillary electrophoresis using electrospray ionization-mass spectrometry detection. J Pharm Biomed Anal. 2014;92:211–9.

Article  CAS  PubMed  Google Scholar 

Chisvert A, Cárdenas S, Lucena R. Dispersive micro-solid phase extraction. TrAC Trends Anal Chem. 2019;112:226–33.

Article  CAS  Google Scholar 

Yahaya N, Mohamad Zain NN, Mohamed AH, Grasianto KS, Miskam M, Jain R, Raoov M, Wan Abdullah WN. Nanosorbents in solid-phase extraction techniques for bioanalysis: a review. Microchem J. 2024;207:112170.

Article  CAS  Google Scholar 

López-Juan AL, Moreno-Calleja LM, Benedé JL, Chisvert A. Dispersive microextraction techniques as efficient strategies for the analysis of saliva: a comprehensive review. J Pharm Biomed Anal. 2025;255:116644.

Article  PubMed  Google Scholar 

Schettino L, Peris-Pastor G, Benedé JL, Chisvert A. A comprehensive review on the use of microextraction techniques in the analysis of cosmetic products. Adv Sample Prepar. 2022;3:100024.

Article  Google Scholar 

Benedé JL, Lucena R, Chisvert A, Cárdenas S. Miniaturized solid-phase extraction. In: Analytical sample preparation with nano- and other high-performance materials. Elsevier, 2021;pp 13–31

García-Atienza P, Martínez-Pérez-Cejuela H, Herrero-Martínez JM, Armenta S. Current trends in the sorbent-based extraction of illegal drugs from biofluids: solid sorbents and configurations. TrAC Trends Anal Chem. 2024;172:117599.

Article  Google Scholar 

Islas G, Ibarra IS, Hernandez P, Miranda JM, Cepeda A. Dispersive solid phase extraction for the analysis of veterinary drugs applied to food samples: a review. Int J Anal Chem. 2017;2017:1–16.

Article  Google Scholar 

López-Sánchez C, de Andrés F, Ríos Á. Implications of analytical nanoscience in pharmaceutical and biomedical fields: a critical view. J Pharm Biomed Anal. 2024;243:116118.

Article  PubMed  Google Scholar 

Grau J, Benedé JL, Chisvert A. Use of nanomaterial-based (micro)extraction techniques for the determination of cosmetic-related compounds. Molecules. 2020;25:2586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lizcano Sanz I, Guzmán Bernardo FJ, Castañeda Peñalvo G, Rodríguez Flores J. Determination of dabrafenib and trametinib in serum by dispersive solid phase extraction with multi-walled carbon nanotubes and capillary electrophoresis coupled to ultraviolet/visible detection. Microchem J. 2021;165:106180.

Article  CAS  Google Scholar 

Solouki Bashiz A, Afshar Mogaddam MR, Nemati M, Siahi-Shadbad M, Farajzade MA, Fathi AA, Shahedi Hojaghan A. Dispersive solid phase extraction of imatinib from human plasma using biological metal-organic and covalent-organic framework composite prior to HPLC-MS/MS. J Chromatogr B. 2025;1256:124558.

Article  CAS  Google Scholar 

Hassani Nouriyeh M, Afshar Mogaddam MR, Nemati M, Farajzadeh MA, Abbasalizadeh A, Shahedi Hojghan A. Development of dispersive solid phase extraction based on magnetic metal organic framework for the extraction of sunitinib in biological samples and its determination by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2024;1239:124109.

Article  CAS